This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Roche Palo Alto LLC. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Jeffrey Wu: Innovator in HIV-1 Treatment
Introduction
Jeffrey Wu is a notable inventor based in Saratoga, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for HIV-1 infections. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Wu's latest patents focus on non-nucleoside reverse transcriptase inhibitors. These compounds, defined by specific formulas, are designed to inhibit HIV-1 reverse transcriptase. They provide methods for the prevention and treatment of HIV-1 infections, as well as the treatment of AIDS and/or ARC. The inventions also include compositions containing these compounds, which are useful for the same purposes.
Career Highlights
Throughout his career, Jeffrey Wu has worked with prominent companies in the pharmaceutical industry, including Roche Palo Alto LLC and F. Hoffmann-La Roche AG. His experience in these organizations has contributed to his expertise in developing innovative treatments.
Collaborations
Wu has collaborated with talented individuals such as Joshua Kennedy-Smith and Zachary Kevin Sweeney. These partnerships have likely enhanced his research and development efforts in the field.
Conclusion
Jeffrey Wu's contributions to HIV-1 treatment through his patents and collaborations highlight his role as an important inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile